Robert M. Blew
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Robert M. Blew has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
- Denise J. Roe
Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ 85724, USA
13 shared publications - Jennifer W. Bea
Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ 85724, USA
12 shared publications - Bette J. Caan
Division of Research, Kaiser Permanente Northern California, Oakland, USA
11 shared publications - Shelby G. Ziller
Affiliation Department of Epidemiology and Biostatistics, The University of Arizona, Tucson, Arizona, United States of America
11 shared publications - Zhao Chen
Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ 85724, USA
11 shared publications - Andrew Odegaard
Department of Epidemiology and Biostatistics, Joe C Wen School of Population & Public Health, University of California, Irvine, USA
9 shared publications
Latest Publications
DXA ‐Derived Abdominal Adiposity and Obesity‐Related Cancer Risk Among Postmenopausal Women in the Women's Health Initiative
Objective: Obesity is associated with the risk of several cancers, yet conventional anthropometric measures do not distinguish the contributions of different compartments of abdominal adipose tissue. This study examined the relationship between visceral (VAT) and subcutaneous (SAT) abdominal adiposity and the incidence of 13 obesity‐related cancers (ObRCs) in postmenopausal women. Methods: Data from 9950 postmenopausal participants in the Women's Health Initiative (WHI) dual‐energy X‐ray absorptiometry (DXA) cohort were analyzed. Abdominal VAT and SAT were quantified from DXA scans using validated imaging software. Fine and Gray competing‐risks models estimated associations with ObRC incidence over 177,295 person‐years of follow‐up. Results: Higher abdominal VAT was significantly associated with higher ObRC risk, independently of BMI, waist circumference (WC), and other confounders. Each 100‐cm 2 increase in VAT corresponded to a 32% higher risk, with a nearly twofold increase for women in the highest VAT quartile. SAT and the VAT/SAT ratio were also significantly associated with risk, though more modestly. Findings were consistent across BMI, WC, age, and race/ethnicity strata and in time‐varying models. Conclusions: Visceral adiposity has a strong, independent association with ObRC risk in postmenopausal women. Incorporating imaging‐based body composition measures may improve cancer risk stratification and guide targeted prevention strategies. Trial Registration: ClinicalTrials.gov identifier: NCT00000611 https://clinicaltrials.gov/study/NCT00000611
DXA ‐Derived Abdominal Adiposity and Obesity‐Related Cancer Risk Among Postmenopausal Women in the Women's Health Initiative
Objective: Obesity is associated with the risk of several cancers, yet conventional anthropometric measures do not distinguish the contributions of different compartments of abdominal adipose tissue. This study examined the relationship between visceral (VAT) and subcutaneous (SAT) abdominal adiposity and the incidence of 13 obesity‐related cancers (ObRCs) in postmenopausal women. Methods: Data from 9950 postmenopausal participants in the Women's Health Initiative (WHI) dual‐energy X‐ray absorptiometry (DXA) cohort were analyzed. Abdominal VAT and SAT were quantified from DXA scans using validated imaging software. Fine and Gray competing‐risks models estimated associations with ObRC incidence over 177,295 person‐years of follow‐up. Results: Higher abdominal VAT was significantly associated with higher ObRC risk, independently of BMI, waist circumference (WC), and other confounders. Each 100‐cm 2 increase in VAT corresponded to a 32% higher risk, with a nearly twofold increase for women in the highest VAT quartile. SAT and the VAT/SAT ratio were also significantly associated with risk, though more modestly. Findings were consistent across BMI, WC, age, and race/ethnicity strata and in time‐varying models. Conclusions: Visceral adiposity has a strong, independent association with ObRC risk in postmenopausal women. Incorporating imaging‐based body composition measures may improve cancer risk stratification and guide targeted prevention strategies. Trial Registration: ClinicalTrials.gov identifier: NCT00000611 https://clinicaltrials.gov/study/NCT00000611
- Open Access
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table S3 from Dual-energy X-ray Absorptiometry–Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women
Supplemental Table S3: Model results separated out for colorectal, colon, and rectal cancer incidence
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S3 from Dual-energy X-ray Absorptiometry–Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women
Supplemental Table S3: Model results separated out for colorectal, colon, and rectal cancer incidence
- Open Access
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table S4 from Dual-energy X-ray Absorptiometry–Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women
Supplemental Table S4: Model results stratified by BMI category
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S4 from Dual-energy X-ray Absorptiometry–Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women
Supplemental Table S4: Model results stratified by BMI category
- Open Access
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table S1 from Dual-energy X-ray Absorptiometry–Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women
Supplemental Table S1: Model results additionally adjusted for BMI and SMI, and time-varying model results
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S1 from Dual-energy X-ray Absorptiometry–Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women
Supplemental Table S1: Model results additionally adjusted for BMI and SMI, and time-varying model results
- Open Access
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table S2 from Dual-energy X-ray Absorptiometry–Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women
Supplemental Table S2: Model results for baseline and time-varying quartile analysis
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S2 from Dual-energy X-ray Absorptiometry–Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women
Supplemental Table S2: Model results for baseline and time-varying quartile analysis
- Open Access
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Data from Dual-energy X-ray Absorptiometry–Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women
Background:Determine if dual-energy X-ray absorptiometry (DXA)–derived adiposity was associated with colorectal cancer incidence and mortality in postmenopausal women from the Women’s Health Initiative DXA cohort.Methods:Whole-body DXA scans estimated adiposity. Women with a history of cancer (except nonmelanoma skin cancer) or missing baseline DXA were excluded. For 27 years of follow-up, outcomes and deaths were adjudicated. Descriptive statistics by colorectal cancer status were calculated. Fine and Gray’s competing risks regression was used to estimate sub-HRs and 95% confidence intervals. Observation time was from enrollment to the first colorectal cancer event or competing risk (other cancer, other cause of death); women without cancer at the last follow-up were censored. Covariates included sociodemographic, clinical, and study characteristics.Results:After exclusions, 9,950 women were included, with 191 first-incident colorectal cancer cases and 88 colorectal cancer–related deaths identified. At baseline, the mean (±SD) age was 63.3 (±7.4) years, and the body mass index (BMI) was 28.2 (±5.7) kg/m2. In adjusted models, baseline continuous abdominal visceral adipose tissue (VAT; per 100 cm2) and android fat (per kg) were significantly associated with a higher risk of first-incident colorectal cancer: sub-HRs (95% confidence interval) were 1.23 (1.04–1.45) and 1.15 (1.01–1.31), respectively. There were no significant associations between adiposity and colorectal cancer mortality.Conclusions:Higher amounts of abdominal VAT and android fat were associated with a higher risk of colorectal cancer incidence in postmenopausal women.Impact:Associations between VAT and colorectal cancer, independent of BMI, support the clinical assessment of body composition across weight categories. A head-to-head comparison of VAT and BMI for colorectal cancer prediction is recommended in future research.
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Dual-energy X-ray Absorptiometry–Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women
Background:Determine if dual-energy X-ray absorptiometry (DXA)–derived adiposity was associated with colorectal cancer incidence and mortality in postmenopausal women from the Women’s Health Initiative DXA cohort.Methods:Whole-body DXA scans estimated adiposity. Women with a history of cancer (except nonmelanoma skin cancer) or missing baseline DXA were excluded. For 27 years of follow-up, outcomes and deaths were adjudicated. Descriptive statistics by colorectal cancer status were calculated. Fine and Gray’s competing risks regression was used to estimate sub-HRs and 95% confidence intervals. Observation time was from enrollment to the first colorectal cancer event or competing risk (other cancer, other cause of death); women without cancer at the last follow-up were censored. Covariates included sociodemographic, clinical, and study characteristics.Results:After exclusions, 9,950 women were included, with 191 first-incident colorectal cancer cases and 88 colorectal cancer–related deaths identified. At baseline, the mean (±SD) age was 63.3 (±7.4) years, and the body mass index (BMI) was 28.2 (±5.7) kg/m2. In adjusted models, baseline continuous abdominal visceral adipose tissue (VAT; per 100 cm2) and android fat (per kg) were significantly associated with a higher risk of first-incident colorectal cancer: sub-HRs (95% confidence interval) were 1.23 (1.04–1.45) and 1.15 (1.01–1.31), respectively. There were no significant associations between adiposity and colorectal cancer mortality.Conclusions:Higher amounts of abdominal VAT and android fat were associated with a higher risk of colorectal cancer incidence in postmenopausal women.Impact:Associations between VAT and colorectal cancer, independent of BMI, support the clinical assessment of body composition across weight categories. A head-to-head comparison of VAT and BMI for colorectal cancer prediction is recommended in future research.
- Open Access
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S2 from Dual-energy X-ray Absorptiometry–Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women
Supplemental Figure S2: Spearman's Rank Correlations of baseline fat measurements
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S2 from Dual-energy X-ray Absorptiometry–Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women
Supplemental Figure S2: Spearman's Rank Correlations of baseline fat measurements
- Open Access
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S1 from Dual-energy X-ray Absorptiometry–Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women
Supplemental Figure S1: CONSORT Diagram of participants included in the analyses
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S1 from Dual-energy X-ray Absorptiometry–Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women
Supplemental Figure S1: CONSORT Diagram of participants included in the analyses
- Open Access
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table S5 from Dual-energy X-ray Absorptiometry–Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women
Supplemental Table S5: Model results stratified by race and ethnicity
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S5 from Dual-energy X-ray Absorptiometry–Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women
Supplemental Table S5: Model results stratified by race and ethnicity
- 1 August 2025
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 34 (10) , 1801-1809
Dual-energy X-ray Absorptiometry–Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women
Background: Determine if dual-energy X-ray absorptiometry (DXA)–derived adiposity was associated with colorectal cancer incidence and mortality in postmenopausal women from the Women’s Health Initiative DXA cohort. Methods: Whole-body DXA scans estimated adiposity. Women with a history of cancer (except nonmelanoma skin cancer) or missing baseline DXA were excluded. For 27 years of follow-up, outcomes and deaths were adjudicated. Descriptive statistics by colorectal cancer status were calculated. Fine and Gray’s competing risks regression was used to estimate sub-HRs and 95% confidence intervals. Observation time was from enrollment to the first colorectal cancer event or competing risk (other cancer, other cause of death); women without cancer at the last follow-up were censored. Covariates included sociodemographic, clinical, and study characteristics. Results: After exclusions, 9,950 women were included, with 191 first-incident colorectal cancer cases and 88 colorectal cancer–related deaths identified. At baseline, the mean (±SD) age was 63.3 (±7.4) years, and the body mass index (BMI) was 28.2 (±5.7) kg/m2. In adjusted models, baseline continuous abdominal visceral adipose tissue (VAT; per 100 cm2) and android fat (per kg) were significantly associated with a higher risk of first-incident colorectal cancer: sub-HRs (95% confidence interval) were 1.23 (1.04–1.45) and 1.15 (1.01–1.31), respectively. There were no significant associations between adiposity and colorectal cancer mortality. Conclusions: Higher amounts of abdominal VAT and android fat were associated with a higher risk of colorectal cancer incidence in postmenopausal women. Impact: Associations between VAT and colorectal cancer, independent of BMI, support the clinical assessment of body composition across weight categories. A head-to-head comparison of VAT and BMI for colorectal cancer prediction is recommended in future research.
- 1 August 2025
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 34 (10) , 1801-1809
Dual-energy X-ray Absorptiometry–Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women
Background: Determine if dual-energy X-ray absorptiometry (DXA)–derived adiposity was associated with colorectal cancer incidence and mortality in postmenopausal women from the Women’s Health Initiative DXA cohort. Methods: Whole-body DXA scans estimated adiposity. Women with a history of cancer (except nonmelanoma skin cancer) or missing baseline DXA were excluded. For 27 years of follow-up, outcomes and deaths were adjudicated. Descriptive statistics by colorectal cancer status were calculated. Fine and Gray’s competing risks regression was used to estimate sub-HRs and 95% confidence intervals. Observation time was from enrollment to the first colorectal cancer event or competing risk (other cancer, other cause of death); women without cancer at the last follow-up were censored. Covariates included sociodemographic, clinical, and study characteristics. Results: After exclusions, 9,950 women were included, with 191 first-incident colorectal cancer cases and 88 colorectal cancer–related deaths identified. At baseline, the mean (±SD) age was 63.3 (±7.4) years, and the body mass index (BMI) was 28.2 (±5.7) kg/m2. In adjusted models, baseline continuous abdominal visceral adipose tissue (VAT; per 100 cm2) and android fat (per kg) were significantly associated with a higher risk of first-incident colorectal cancer: sub-HRs (95% confidence interval) were 1.23 (1.04–1.45) and 1.15 (1.01–1.31), respectively. There were no significant associations between adiposity and colorectal cancer mortality. Conclusions: Higher amounts of abdominal VAT and android fat were associated with a higher risk of colorectal cancer incidence in postmenopausal women. Impact: Associations between VAT and colorectal cancer, independent of BMI, support the clinical assessment of body composition across weight categories. A head-to-head comparison of VAT and BMI for colorectal cancer prediction is recommended in future research.